S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 178 HKD 3.43% Market Closed
Market Cap: 38.4B HKD
Have any thoughts about
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?
Write Note

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Effect of Foreign Exchange Rates
ÂĄ19.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Effect of Foreign Exchange Rates
ÂĄ44.1m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Effect of Foreign Exchange Rates
ÂĄ18.5m
CAGR 3-Years
N/A
CAGR 5-Years
47%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Effect of Foreign Exchange Rates
ÂĄ7.6m
CAGR 3-Years
N/A
CAGR 5-Years
50%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Effect of Foreign Exchange Rates
-ÂĄ2.8m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Effect of Foreign Exchange Rates
-ÂĄ2.1m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Glance View

Market Cap
39.7B HKD
Industry
Biotechnology

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Chengdu, Sichuan and currently employs 1,155 full-time employees. The company went IPO on 2023-07-11. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The firm is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The firm's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.

Intrinsic Value
144.1 HKD
Overvaluation 19%
Intrinsic Value
Price
S

See Also

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
19.4m CNY

Based on the financial report for Dec 31, 2023, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Effect of Foreign Exchange Rates amounts to 19.4m CNY.

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 1Y
2 623%

Over the last year, the Effect of Foreign Exchange Rates growth was 2 623%.

Back to Top